Adipokine levels and depression in individuals aged ≥ 90 years: is there an association?

Read full text
Authors: Paulina Zabielska, Małgorzata Szkup, Artur Kotwas, Tomasz Śluzar, Beata Karakiewicz
Cited by: 0
References: 33

Abstract

INTRODUCTION: The aim of the study was to investigate the relationship between adipokine levels (adiponectin and resistin) and depressive affect in individuals aged 90 and over. MATERIAL AND METHODS: The study included 90 individuals of both sexes aged between 90 and 103 years (mean = 92.36; SD = 2.98). The study was based on a diagnostic survey, administered through face-to-face interviews. The prevalence of depression in the study group was assessed using a screening test, the 15-item Geriatric Depression Scale (GDS). Blood samples were collected in accordance with the relevant regulations and procedures for the collection, storage and transport of biological material. All patients were thoroughly informed about the scope and objectives of the study and gave their written consent to participate. RESULTS: Univariate analysis revealed a link between elevated resistin levels (OR = 1.254 p = 0.006) and depression. In multivariate analysis, after adjusting for potential confounders, resistin levels > 6.95 remained significantly associated with an increased likelihood of depression (OR = 5.394, p = 0.001). CONCLUSIONS: The results of the study indicate that higher serum resistin levels are associated with depressive symptoms in individuals aged 90 years and older, independently of metabolic, inflammatory, and hormonal factors. These findings provide preliminary evidence of a potential link between resistin and depressive affect in the oldest-old population; however, due to the study’s design, causality or temporal sequence cannot be determined.

Fields of Study & Subjects

Adipokines Inflammation and Metabolic Diseases Nutrition and Health in Aging HIV-related health complications and treatments

Publication details

Journal / source
BMC Geriatrics
Volume
26
Issue
1
Pages
175–175
Publication date
9 January 2026
Language
EN